pickyourbaby.com
PickYourBaby.com is a bold advertising gateway for Nucleus Genomics, a company that sells genetic testing and embryo comparison tools for people planning a family.
What is PickYourBaby.com?
The website is not a baby-name guide, parenting blog, or place where someone can create a child online.
The domain redirects visitors to a Nucleus app with tracking labels for its print and subway campaign.
This shows the site’s main job clearly.
It turns attention from a striking web address into sales leads for Nucleus.
The campaign began with ads across New York that told people to “Have Your Best Baby.”
Nucleus says the campaign aims to teach families about tools that may show a future child’s health risks and traits, including predicted IQ.
What does Nucleus actually offer?
Nucleus sells several connected products for family planning and IVF.
Nucleus Preview uses DNA from prospective parents to estimate what a future child might inherit.
Nucleus Embryo works with people who already have embryos made through IVF.
The company says its software can compare up to 20 embryos for rare conditions, long-term health risks, and traits such as height and IQ.
Its current FAQ lists Nucleus Embryo at $9,999.
The larger IVF+ service includes clinic matching, one IVF cycle, medicines, testing, embryo analysis, and access to genetic counselors.
IVF+ starts at $9,999 per month for four months, although the final price depends on the clinic and location.
Does the service edit a baby’s genes?
No, the service compares genetic data from existing embryos rather than changing their DNA.
Nucleus normally uses embryo data produced through preimplantation genetic testing at an IVF laboratory.
Its software then presents estimates and comparisons to help parents decide which embryo they may want transferred.
This difference matters because “designer baby” can make people think scientists are adding or removing genes.
The service is better described as embryo selection guided by genetic predictions.
The choice can still shape which embryo develops into a child, so it remains a serious decision even without gene editing.
How reliable are its predictions?
Some genetic findings are much clearer than others.
A harmful change in one known gene can provide strong evidence about a specific inherited disorder.
Height, intelligence, diabetes, heart disease, and many mental health conditions involve many genes plus food, care, education, stress, and other parts of life.
Nucleus itself says these complex results are estimates of likelihood, not firm predictions.
This means a lower score does not promise that a child will avoid a disease.
A higher score does not prove that a child will develop it.
The American Society for Reproductive Medicine reached a much more cautious position in December 2025.
Its committees said polygenic embryo screening is not ready for clinical use because its accuracy, safety, and medical value have not been proved.
They also warned that current data do not represent all groups equally.
Why has the website caused such a strong reaction?
The name PickYourBaby.com makes a hard medical process sound like simple online shopping.
That is powerful marketing, but it also removes much of the pain and uncertainty found in real IVF care.
Parents may have only a few viable embryos, and the predicted differences between them may be small.
The phrase “best baby” also suggests that one possible child has more value than another.
Critics connect this idea with eugenics because trait selection can favor narrow views of health, ability, beauty, and success.
Supporters answer that parents should be allowed to use available information to reduce serious disease risks.
Both views become harder to separate when one screen mixes strong single-gene findings with uncertain scores for IQ or appearance.
What should prospective customers examine first?
Customers should ask which results identify a known gene variant and which come from a polygenic model.
They should request the absolute risk for each condition, not only a rank or colored score.
They should also ask how much two embryos truly differ and whether that difference changes the medical advice.
An independent reproductive doctor or genetic counselor can help test the company’s sales message against the limits of the evidence.
Privacy deserves equal attention because DNA data cannot be replaced like a password.
Nucleus says it does not give genetic data to employers, insurers, public databases, or marketers, but its privacy policy permits certain disclosures to service providers, affiliates, legal authorities, and parties involved in a change of ownership.
The policy also says no online storage system can be completely secure.
What is the clearest way to judge PickYourBaby.com?
PickYourBaby.com is best understood as the sharp edge of a larger sales funnel, not as a neutral medical guide.
The service brings real genetic tools into a clean and easy interface.
It also places proven tests and uncertain predictions close together.
That design can make every result feel equally useful even when the science behind each result is very different.
The key question is therefore not whether more genetic information sounds helpful.
The key question is whether each piece of information is accurate enough to guide an irreversible choice.